At CD BioGlyco, we recognize that even the most elegantly designed metabolic pathway underperforms if the fermentation environment is not synchronized with the organism's innate biological tempo. Our fermentation kinetics optimization service is engineered to bridge this gap, transforming theoretical yields into tangible, high-titer realities. Fermentation kinetics involves the quantitative study of the rates of cell growth, substrate consumption, and product formation. By applying rigorous mathematical modeling and real-time data acquisition, we decode the dynamic relationship between your engineered strains and their environment. Whether you are producing complex glycoproteins, human milk oligosaccharides (HMOs), or rare sugar derivatives, our service ensures that every metabolic flux is directed toward your target molecule with maximum efficiency. Through this service, CD BioGlyco empowers researchers and industrial partners to move beyond trial-and-error methodologies, adopting a predictive and precision-driven approach to biomanufacturing.
Key Technologies
Mechanistic Kinetic Modeling (MKM)
Unlike standard empirical observations, our MKM utilizes ordinary differential equations (ODEs) to describe the biochemical reactions within the fermenter. We analyze the specific growth rate (µ), metabolic saturation constants (Ks), and yield coefficients (Yp/s) to create a "digital twin" of your fermentation process. This allows us to simulate thousands of scenariosin silico, identifying the optimal feeding strategies and induction points before a single liter of media is consumed.
Metabolic Flux Analysis (MFA)
We employ MFA to quantify the flow of carbon and nitrogen through the central metabolic pathways and the heterologous glycan synthesis routes. By using 13C-labeling and mass spectrometry, we can pinpoint metabolic bottlenecks and "by-product leakage." This technology allows us to adjust kinetic parameters to ensure that precursors are channeled toward glycosylation rather than competing biomass pathways.
Real-Time Online Monitoring
Our integration of process analytical technology (PAT) involves the use of in-situ sensors for dissolved oxygen (DO), pH, CO2 evolution rates (CER), and biomass concentrations. By linking these sensors to our automated control systems, we implement dynamic kinetic adjustments during the run, ensuring that the environment evolves in perfect harmony with the culture's metabolic state.
Unlocking the Kinetic Potential of Synthetic Glycobiology Through Data-Driven Optimization
At CD BioGlyco, our fermentation kinetics optimization service is a specialized vertical within our broader synthetic biology-based fermentation service. This offering is specifically designed for clients who have already developed a chassis but are struggling with low titers, inconsistent product quality, or poor scalability. We provide a suite of solutions that address the multi-dimensional nature of microbial growth and product synthesis.
The core of our service involves the determination of critical kinetic parameters that govern the bioprocess. We look beyond simple "end-point" measurements to understand the velocity of the system. Our scope includes:
Substrate Consumption Dynamics: We analyze how different carbon sources (glucose, glycerol, and methanol) affect the metabolic rate and the glycosylation patterns of the final product.
Inhibition Modeling: Many glycan products or metabolic intermediates can be toxic to the host. We characterize inhibition kinetics (competitive and non-competitive) to design feeding profiles that keep concentrations below inhibitory thresholds.
Growth-Linked vs. Non-Growth-Linked Synthesis: We distinguish whether your product is formed during the exponential phase or the stationary phase, allowing us to tailor the duration and intensity of the fermentation stages.
By operating at the intersection of chassis development and fermentation process optimization, we provide a holistic view. We don't just optimize the hardware; we optimize the biological response to the hardware. For projects involving complex glycoconjugates, we pay special attention to the kinetics of glycan precursor pools (e.g., UDP-GlcNAc, GDP-fucose), ensuring that the kinetic rate of protein synthesis does not outpace the rate of glycan attachment, which would otherwise lead to under-glycosylated products. CD BioGlyco ensures that your fermentation process is not just a black box, but a finely tuned engine for high-value glycan production.
Workflow
Preliminary Strain Characterization
We begin by evaluating the baseline performance of the client's engineered strain in shake flasks or micro-bioreactors. This stage establishes the initial growth curves and metabolic requirements.
Multi-Parameter Kinetic Data Acquisition
Using parallel bioreactor systems, we perform a series of runs varying critical factors such as temperature, pH, and substrate concentration. We collect high-resolution data on biomass, substrate depletion, and product accumulation.
Mathematical Model Construction
Our bioinformaticians integrate the collected data into kinetic models. We estimate the maximum specific growth rate (µmax) and identify the rate-limiting steps within the metabolic pathway.
Process Strategy Design
Based on the model, we develop advanced feeding strategies (e.g., exponential feeding, pH-stat, or DO-stat) to maintain optimal kinetic conditions throughout the fermentation cycle.
Pilot-Scale Validation and Refinement
The optimized protocol is tested at a 5L to 50L scale to ensure that the kinetic profiles remain consistent during scale-up. Any deviations are corrected through iterative model refinement.
Reporting and Tech Transfer
Clients receive a detailed kinetic profile report, the optimized fermentation SOP, and all mathematical models used, facilitating a smooth transition to large-scale manufacturing.
Publication Data
DoI: 10.3390/molecules21111479
Journal: Molecules
IF: 4.6
Published: 2016
Results: This study first reports that Thalassospira sp. Fjfst-332 isolated from dried Chondrus crispus degrades κ-carrageenan. The strain was identified via 16S rDNA sequencing and transmission electron microscopy (TEM) observation. Using Plackett–Burman design, Box–Behnken design and response surface methodology, the optimal fermentation medium was determined: 2.0 g/L κ-carrageenan, 1.0 g/L yeast extract, 1.0 g/L FOS, 20.0 g/L NaCl and other trace components. Under optimized conditions, the maximum κ-carrageenase activity reached 267 U/mL, making this strain the most active wild-type bacterium for enzyme production. The Logistic equation and Luedeking–Piret equation were applied to fit fermentation kinetics, with high fitting accuracy (R2 > 0.96). These kinetic models and optimized medium provide a reliable basis for the industrial production of κ-carrageenan oligosaccharides.
Fig.1 The model fitting of revolving speed relative to biomass. (Guo, et al., 2016)
Applications
Therapeutic Glycoprotein Production
Optimizing the kinetics of monoclonal antibody (mAb) and erythropoietin (EPO) production to ensure consistent N-glycosylation and O-glycosylation patterns, which are critical for drug efficacy and safety.
HMO Production
Enhancing the fermentation efficiency of engineered E. coli or yeast to produce HMOs like 2'-fucosyllactose at industrial scales for use in infant formula and specialized nutritional supplements.
Bio-based Specialty Chemicals
Directing metabolic flux toward the synthesis of rare sugars and sugar alcohols used in the cosmetic industries, maximizing yield from renewable feedstocks through precise substrate feeding.
Enzyme Manufacturing
Improving the secretion kinetics of industrial enzymes used in glycoconjugation or biomass degradation, ensuring high enzyme activity and purity while minimizing the production of host-cell proteins.
Advantages
Unparalleled Glyco-expertise
Unlike general fermentation firms, we understand the unique metabolic burdens of glycan synthesis, allowing us to optimize kinetics specifically for carbohydrate-based products and their complex precursors.
High-Throughput Parallelism
Our facility utilizes advanced micro-scale and parallel bioreactors, enabling us to test dozens of kinetic variables simultaneously, shortening the development timeline for our clients.
Predictive Modeling Accuracy
By combining mechanistic models with machine learning (ML), we achieve high predictive accuracy, reducing the number of expensive "wet-lab" iterations required to find the optimal process window.
Scalability Assurance
We focus on kinetic similarity during scale-up, ensuring that the metabolic performance observed in our 1L reactors translates accurately to industrial-scale fermenters without loss of titer.
Frequently Asked Questions
Customer Review
"The team at CD BioGlyco transformed our HMO production process. We were struggling with significant by-product formation that hampered purification. Their kinetic modeling pinpointed a specific substrate inhibition issue we had overlooked. Post-optimization, our titers increased by 40%, and the process is now stable."
– E.S., Principal Scientist, Global Nutrition Biotech.
"We've worked with several CROs, but CD BioGlyco's deep understanding of glycosylation kinetics sets them apart. They didn't just give us a recipe; they gave us a dynamic control strategy that ensured the therapeutic proteins met the strict glycoform requirements."
"Highly impressed with the technical depth of their fermentation kinetics optimization. The transition from their 5L validation to our 100L pilot plant was seamless, with kinetic profiles matching almost perfectly. A truly reliable partner for scale-up."
CD BioGlyco provides an industry-leading fermentation kinetics optimization service that combines advanced mathematical modeling, real-time monitoring, and deep expertise in synthetic glycobiology. By focusing on the quantitative rates of biological processes, we enable our clients to achieve maximum titers, superior product quality, and cost-effective scalability for their most challenging glycan-related products. Please feel free to contact us for more information and to discuss your project.
Reference
Guo, J.; et al. Medium optimization and fermentation kinetics for κ-carrageenase production by Thalassospira sp. Fjfst-332. Molecules. 2016, 21(11): 1479. (Open Access)
For research use only. Not intended for any clinical use.
Fig.1 The model fitting of revolving speed relative to biomass. (Guo, et al., 2016)
